{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:02:34Z","timestamp":1789664554692,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jneuroim.2021.577570","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T11:55:16Z","timestamp":1617796516000},"page":"577570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer"],"prefix":"10.1016","volume":"355","author":[{"given":"Elianet","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Varas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Godoy-Sant\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2021.577570_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","article-title":"Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies","volume":"73","author":"Armangu\u00e9","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0010","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1212\/WNL.0000000000006035","article-title":"Glutamate receptor \u03b42 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome","volume":"91","author":"Berridge","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2021.577570_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mds.870100106","article-title":"The movement disorders of adult opsoclonus","volume":"10","author":"Caviness","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0020","first-page":"55905","article-title":"Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic Kelch-like protein-11 encephalitis","author":"Dubey","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0025","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes for the paraneoplastic neurological syndrome Euronetwork","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2021.577570_bb0030","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"H\u00f6ftberger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2021.577570_bb0035","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/archneurol.2012.1173","article-title":"Adult-onset opsoclonus-myoclonus syndrome","volume":"69","author":"Klaas","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMicm1914516","article-title":"Opsoclonus in anti-MA2 brain-stem encephalitis","author":"Kunchok","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0045","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cei.12185","article-title":"Paraneoplastic neurological syndromes","volume":"175","author":"Leypoldt","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer","volume":"29","author":"Luque","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMoa1816721","article-title":"Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis","volume":"381","author":"Mandel-Brehm","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000666","article-title":"Clinical significance of Kelch-like protein 11 antibodies","volume":"7","author":"Maudes","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/WCO.0b013e328347b307","article-title":"Movement disorders in paraneoplastic and autoimmune disease","volume":"24","author":"Panzer","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0070","series-title":"Handbook of Clinical Neurology","article-title":"Opsoclonus-myoclonus syndrome","author":"Pike","year":"2013"},{"key":"10.1016\/j.jneuroim.2021.577570_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000699","article-title":"Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies","volume":"7","author":"Simard","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420932797","article-title":"Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors","author":"Vogrig","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2021.577570_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.598894","article-title":"Case report: innate immune system challenge unleashes paraneoplastic neurological autoimmunity","volume":"11","author":"Zhu","year":"2020","journal-title":"Front. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:38:57Z","timestamp":1759048737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572821000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":17,"alternative-id":["S0165572821000977"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577570","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577570"}}